Persistent URL of this record https://hdl.handle.net/1887/101816
In Collections
This item can be found in the following collections:
Long-Term Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis with and without Prior Tumor Necrosis Factor Inhibitor Exposure
- All authors
- Mease, P.; Fleischmann, R.; Wollenhaupt, J.; Deodhar, A.A.; Gladman, D.D.; Hoepken, B.; Peterson, L.; Heijde, D.M. van der
- Date
- 2014-10-31
- Journal
- Arthritis and Rheumatology
- Volume
- 66
- Pages
- S237 - S238